JENBURKT PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JENBURKT PHARMACEUTICALS have increased by 11.24% YoY .
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 8.34 % YoY. |
||
JENBURKT PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524731]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹169 Cr | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr |
| Expenses | ₹125 Cr | ₹111 Cr | ₹109 Cr | ₹106 Cr | ₹97 Cr |
| Operating Profit (Excl OI) | ₹44 Cr | ₹40 Cr | ₹33 Cr | ₹30 Cr | ₹27 Cr |
| Other Income | ₹10 Cr | ₹6.72 Cr | ₹4.67 Cr | ₹5.12 Cr | ₹4.95 Cr |
| Interest | ₹0.46 Cr | ₹0.45 Cr | ₹0.27 Cr | ₹0.37 Cr | ₹0.43 Cr |
| Depreciation | ₹3.11 Cr | ₹2.73 Cr | ₹2.34 Cr | ₹2.26 Cr | ₹1.90 Cr |
| Profit Before Tax | ₹47 Cr | ₹44 Cr | ₹35 Cr | ₹33 Cr | ₹30 Cr |
| Profit After Tax | ₹35 Cr | ₹32 Cr | ₹26 Cr | ₹25 Cr | ₹22 Cr |
| Earnings Per Share (Rs) | ₹78.71 | ₹72.65 | ₹58.86 | ₹55.76 | ₹48.58 |
| PAT Margin (%) | 20.59 | 21.14 | 18.30 | 17.99 | 17.98 |
| ROE(%) | 18.84 | 20.25 | 19.43 | 20.53 | 20.66 |
| ROCE(%) | 25.34 | 27.85 | 26.28 | 26.80 | 26.89 |
| Total Debt/Equity(x) | 0.00 | 0.01 | 0.00 | 0.02 | 0.05 |
Key Financials |
||
| Market Cap | : | ₹ 467.5 Cr |
| Revenue (TTM) | : | ₹ 168.7 Cr |
| Net Profit(TTM) | : | ₹ 32.8 Cr |
| EPS (TTM) | : | ₹ 74.6 |
| P/E (TTM) | : | 14.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JENBURKT PHARMACEUTICALS | -2.6% | -3.5% | -11.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 0.5% | 14% |
| DIVIS LABORATORIES | -0.9% | 21.1% | 25.6% |
| TORRENT PHARMACEUTICALS | -1.3% | 1.1% | 32.7% |
| CIPLA | 0.2% | 2.1% | -5.1% |
| DR REDDYS LABORATORIES | 0.2% | -7.7% | -7.5% |
| MANKIND PHARMA | -1.4% | -3.7% | -5.3% |
| LUPIN | -0.7% | -5.7% | 24% |
| ZYDUS LIFESCIENCES | -0.1% | -3.9% | 14.1% |
JENBURKT PHARMACEUTICALS Revenues
[BOM: 524731]
| Y-o-Y | 11.24 % |
| 5 Yr CAGR | 8.01 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹169 Cr | 11.24 | |
| Mar2025 | ₹152 Cr | 6.85 | |
| Mar2024 | ₹142 Cr | 3.82 | |
| Mar2023 | ₹137 Cr | 10.30 | |
| Mar2022 | ₹124 Cr | - | |
JENBURKT PHARMACEUTICALS Operating Profit
[BOM: 524731]
| Y-o-Y | 8.29 % |
| 5 Yr CAGR | 12.55 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 Cr | 8.29 | |
| Mar2025 | ₹40 Cr | 21.96 | |
| Mar2024 | ₹33 Cr | 9.06 | |
| Mar2023 | ₹30 Cr | 11.42 | |
| Mar2022 | ₹27 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -2.67 % |
| 5 Yr CAGR | 4.21 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 25.92% | -2.67 | |
| Mar2025 | 26.63% | 14.14 | |
| Mar2024 | 23.33% | 5.04 | |
| Mar2023 | 22.21% | 1.05 | |
| Mar2022 | 21.98% | - | |
JENBURKT PHARMACEUTICALS Profit After Tax
[BOM: 524731]
| Y-o-Y | 8.34 % |
| 5 Yr CAGR | 11.72 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹35 Cr | 8.34 | |
| Mar2025 | ₹32 Cr | 23.42 | |
| Mar2024 | ₹26 Cr | 5.57 | |
| Mar2023 | ₹25 Cr | 10.36 | |
| Mar2022 | ₹22 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -2.60 % |
| 5 Yr CAGR | 3.45 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 20.59 % | -2.60 | |
| Mar2025 | 21.14 % | 15.52 | |
| Mar2024 | 18.3 % | 1.72 | |
| Mar2023 | 17.99 % | 0.06 | |
| Mar2022 | 17.98 % | - | |
JENBURKT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524731]
| Y-o-Y | 8.34 % |
| 5 Yr CAGR | 12.82 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹79 | 8.34 | |
| Mar2025 | ₹73 | 23.43 | |
| Mar2024 | ₹59 | 5.56 | |
| Mar2023 | ₹56 | 14.78 | |
| Mar2022 | ₹49 | - | |
JENBURKT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524731]
| Y-o-Y | -9.01 % |
| 5 Yr CAGR | -1.47 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 25.34% | -9.01 | |
| Mar2025 | 27.85% | 5.97 | |
| Mar2024 | 26.28% | -1.94 | |
| Mar2023 | 26.8% | -0.33 | |
| Mar2022 | 26.89% | - | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,062.5 |
| Current MarketCap | : | ₹ 467.5 Cr |
| Updated EOD on | : | Aug 07,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.6% |
-3.5% |
-11.6% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
JENBURKT PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about JENBURKT PHARMACEUTICALS Financials
How the annual revenues of JENBURKT PHARMACEUTICALS have changed ?
The Revenues of JENBURKT PHARMACEUTICALS have increased by 11.24% YoY .
How the Earnings per Share (EPS) of JENBURKT PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 8.34 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs